Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein (GCKR) Inhibition: GCKR-Leu446Pro Variant in Look AHEAD

BACKGROUND: Glucokinase regulatory protein (GCKR) inhibitors offer a novel treatment approach for glucose control in diabetes; however their cardiometabolic effects, particularly in relation to increased triglycerides and C-reactive protein (CRP) levels are of concern. GCKR Leu446Pro is a common var...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Circ Cardiovasc Genet
Asıl Yazarlar: Belalcazar, L. Maria, Papandonatos, George D., Erar, Bahar, Peter, Inga, Alkofide, Hadeel, Balasubramanyam, Ashok, Brautbar, Ariel, Kahn, Steven E., Knowler, William C., Ballantyne, Christie M., McCaffery, Jeanne M., Huggins, Gordon S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4758870/
https://ncbi.nlm.nih.gov/pubmed/26578543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGENETICS.115.001192
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller